Controlled Clinical TrialtcVNSn = 9

Non-invasive vagus nerve stimulation (nVNS) as symptomatic treatment of migraine in young patients: a preliminary safety study

Grazzi L, Egeo G, Liebler E, Padovan AM, Barbanti P

Neurological Sciences · 2017

Key finding

In adolescents/young patients, cervical nVNS aborted 46.8% of treated attacks (22/47) without rescue medication and produced no device-related adverse events, supporting safety.

Condition
Migraine
Stimulation
tcVNS
Evidence tier
Controlled Clinical Trial
Participants
9
View on DOI

Cite this study

Grazzi, L., Egeo, G., Liebler, E., Padovan, A. M., & Barbanti, P. (2017). Non-invasive vagus nerve stimulation (nVNS) as symptomatic treatment of migraine in young patients: a preliminary safety study. Neurological Sciences, 38(S1), 197-199. https://doi.org/10.1007/s10072-017-2942-5

Related studies in Migraine

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.